Chytrid Treatments and Their Compatibility with Amphibian Tissue
ISEF · 2015 Third Award
Overview
The disease Chytridiomycosis (caused by the fungus Batrachochytrium dendrobatidis) has been detrimentally affecting amphibian populations for the past two decades. To make matters worse, there is no cure for the disease. This experimentation compared existing treatments for Chytridiomycosis to a novel treatment, Lactobacillus hammesii. Both the treatments’ compatibility with amphibian cells and their effectiveness at controlling B. dendrobatidis were tested. To compare compatibility, amphibian cells were exposed to each treatment. The amount of lactate dehydrogenase (LDH) was then measured after exposure using a spectophotometer. To compare the treatments’ effectiveness, a non-pathogenic model species for Bd was exposed to each treatment. The area of the fungal colonies remaining after exposure was measured. After data analysis, it was concluded that all treatments are compatible with amphibian cells. The most effective treatments at controlling fungal growth were Lactobacillus hammesii (the novel treatment) and Bacillus subtilis. These two treatments could lead to a cure for Chytridiomycosis.
Awards (1)
- Third Award of $1,000 $1,000
Competition history
- ISEF 2015
Resources
Related projects
ISEF · 2017
Cutaneous Skin Bacteria: A Search for Antifungal Activity
ISEF · 2018
Exploring the Use of Bacteria in Mitigating Fungal Disease
ISEF · 2023
Identifying Novel Modes of Inhibition of C. pusillum and B. subtilis Bacteria, Against Deadly Bat Fungus, Pseudogymnoascus destructans (Year 8)
ISEF · 2018
Elucidating the Influence of Habitat Fragmentation, Urbanization, and Environmental Factors on the Inhibitory Ability of Antifungal Cutaneous Bacteria Found on the Eastern Redback Population
Closest projects by meaning, across every fair and year in the corpus.
Source: Regeneron International Science and Engineering Fair